U.S. Federal Trade Commission: FTC closes investigation into Caremark Rx, Inc./AdvancePC
MLex Summary: The Federal Trade Commission has closed its investigation of Caremark Rx, Inc.’s proposed acquisition of AdvancePCS. The transaction involves two of the largest providers of prescription benefit management (“PBM”)...To view the full article, register now.
Already a subscriber? Click here to view full article